Negligible role of TRAIL death receptors in cell death upon endoplasmic reticulum stress in B-cell malignancies.
Francesca FavaroDemi BothIngrid A M DerksMarcel SpaargarenCristina Muñoz-PinedoEric ElderingPublished in: Oncogenesis (2023)
Impairments in protein folding in the endoplasmic reticulum (ER) lead to a condition called ER stress, which can trigger apoptosis via the mitochondrial or the death receptor (extrinsic) pathway. There is controversy concerning involvement of the death receptor (DR)4 and DR5-Caspase-8 -Bid pathway in ER stress-mediated cell death, and this axis has not been fully studied in B-cell malignancies. Using three B-cell lines from Mantle Cell Lymphoma, Waldenström's macroglobulinemia and Multiple Myeloma origins, we engineered a set of CRISPR KOs of key components of these cell death pathways to address this controversy. We demonstrate that DR4 and/or DR5 are essential for killing via TRAIL, however, they were dispensable for ER-stress induced-cell death, by Thapsigargin, Brefeldin A or Bortezomib, as were Caspase-8 and Bid. In contrast, the deficiency of Bax and Bak fully protected from ER stressors. Caspase-8 and Bid were cleaved upon ER-stress stimulation, but this was DR4/5 independent and rather a result of mitochondrial-induced feedback loop subsequent to Bax/Bak activation. Finally, combined activation of the ER-stress and TRAIL cell-death pathways was synergistic with putative clinical relevance for B-cell malignancies.
Keyphrases
- cell death
- endoplasmic reticulum
- endoplasmic reticulum stress
- cell cycle arrest
- induced apoptosis
- editorial comment
- stress induced
- multiple myeloma
- oxidative stress
- estrogen receptor
- breast cancer cells
- signaling pathway
- binding protein
- crispr cas
- cancer therapy
- genome wide
- newly diagnosed
- high glucose
- small molecule
- drug induced
- gene expression
- drug delivery
- amino acid
- protein protein
- endothelial cells
- pi k akt
- replacement therapy